3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
5
Withdrawn
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
1
Keratosis
1
Interventions
Nivolumab
7
pembrolizumab
4
Ipilimumab
4
cemiplimab
3
Specimen Handling
3
relatlimab
2
Watchful Waiting
2
Standard of Care
2
Prednisone
2
Phototherapy
2
Photochemotherapy
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
Dermoscopy
2
Cryotherapy
2
Carboplatin
2
vedolizumab
1
trametinib
1
toripalimab
1
tirbanibulin
1
sulforaphane
1
gadopiclenol
1
famitinib
1
decitabine and cedazuridine drug combination
1
daromun
1
calcipotriene
1
anlotinib
1
X-Rays
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
tirbanibulin
×
Dermatologic
×
Clear all
NCT07273656
2026-05-22
TIRBACRYO
University Hospital, Lille
Phase 3
Not yet recruiting
59 enrolled